Biotechnology News

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}                  Lancement d'une...

CAMBRIDGE, Mass., Jan. 7, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...

NEWARK, Calif., Jan. 7, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Eliseo Salinas, M.D., Executive Vice President and Head of Research and Development, will provide an...

SAN DIEGO, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and...

CARMIEL, Israel, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that Dr. David Aviezer, the Company's President and Chief Executive Officer,...

PORTLAND, Ore., Jan. 7, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...

PORTLAND, Ore., Jan. 6, 2014 (GLOBE NEWSWIRE) -- Paulson Capital Corp. (Nasdaq:PLCC) (the "Company") today announced that it is expected that, effective on January 8, 2014, the Company's common stock...

MIGDAL HA'EMEQ, Israel, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced...

Bilan semestriel du contrat de liquidité VALNEVA contracté avec NATIXIS    Au titre du contrat de liquidité confié à NATIXIS portant sur les actions de la société VALNEVA, à la date du 31 décembre...

VALNEVA Déclaration d'actions et de droits de vote -  DECEMBRE 2013 Dénomination sociale : VALNEVA Adresse du siège social : 70, rue Saint-Jean de Dieu Marché réglementé Euronext Paris de Nyse...